Studying Red Light and Blood Flow in Healthy Adults

This study is looking at how 670 nm light (a type of red light) affects blood flow in healthy adults. You would receive 670 nm light on your leg and also an infusion of octafluoropropane, a substance used with ultrasound to measure blood flow. Researchers want to see if this red light can increase blood flow in your leg muscle. The study aims to enroll 40 healthy adults between 18 and 59 years old. The current status of this study is unclear, so it's not known if they are actively recruiting participants.

Study design
This is an interventional study planning to enroll 40 healthy participants. All participants will receive the 670 nm light intervention.
What's involved
You would have one study visit where you receive red light on your leg and a continuous infusion of octafluoropropane. Blood flow measurements will be taken before, during, and after the light exposure.
Compensation
Not stated in the trial record.
Follow-up
Blood flow changes will be measured at 10 minutes, and you will be monitored post-procedure. The study will then be completed.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT02370199

Peripheral Blood Flow Responses to Electromagnetic Energy

Recruiting
NAAges 18–59InterventionalBasic science
University of Alabama at Birmingham
~40 participants
Updated 2026-05-01 on ClinicalTrials.gov
What's tested:670 nm lightoctafluropropane

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in blood flow (using octafluoropropane infusion and ultrasound)
Measured over 10 minutes
Exposure to Man-made Visible Light
1 sites across 1 states
Wisconsin1
  • Nicole L Lohr, MD, PhD · PRINCIPAL_INVESTIGATOR · Medical College of Wisconsin

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participants will be healthy subjects over the age of 18.
Men and women will be recruited for participation.
All ethnicities will be included in this study.

Exclusion

age under 18 years and those over 60 years of age,
those who are unable to understand the consent process,
those who cannot read or speak English,
a history of cancer,
peripheral artery disease,
diabetes mellitus,
active pregnancy,
hypersensitivity to perflutren contrast agents,
pulmonary hypertension,
chronic kidney disease,
active tobacco or drug use,
blood pressure over 160/90, BMI\>30,
sickle cell disease, or
history of intracardiac shunt.
a history of coronary artery disease,
heart failure,
the presence of an implanted defibrillator or pacemaker,
a history of heart murmur or rhythm disorder (atrial fibrillation, atrial tachycardia, or ventricular tachycardia),
neurological diseases such as stroke, and
any uncontrolled medical conditions.
  • Change in blood flow (using octafluoropropane infusion and ultrasound)10 minutes

    Blood flow changes based on ultrasound imaging